Searchable abstracts of presentations at key conferences in endocrinology

ea0091we1 | Workshop E: Disorders of the gonads | SFEEU2023

Infertile Couple: Spermatogenesis in Congenital Panhypopituitarism

Grixti Lydia , Quinton Richard

A 31-year-old gentleman presented to our Endocrine Services with his 20-year-old fiancée with plans for marriage and to conceive. He was diagnosed with congenital panhypopituitarism and absent pituitary stalk at the age of 4. He was started on replacement growth hormone, desmopressin, levothyroxine, hydrocortisone and testosterone, in this sequence, across the years. He underwent induction of puberty at the age of 13 years. He was noticed to have bilateral cryptorchidism ...

ea00100wa2.4 | Workshop A: Disorders of the hypothalamus and pituitary (I) | SFEEU2024

Isolated arginine vasopressin deficiency

Grixti Lydia , Gan Earn

An 84-year-old lady presented with a month’s history of polyuria and polydipsia. She reported waking up seven times during the night to pass urine and constantly feeling thirsty. Her measured 24-hour urine output was 4.9 L. She was otherwise doing well with a past medical history of hypertension, hyperlipidaemia, gastro-oesophageal reflux disease and prolonged hospital admission 20 years ago for Guillain Barré syndrome. Her drug history included Lisinopril, Atorvasta...

ea0104p59 | Bone & Calcium | SFEIES24

A very rare presentation of severe hypercalcemia due to sarcoid like granulomatous myositis

Mutar Sarah , Grixti Lydia , Leng Owain , Goff Iain , Madathil Asgar

Introduction: Granulomatous myositis (GM) is a very rare inflammatory condition and can cause PTH- independent hypercalcemia. The hypercalcaemia is due to the elevated levels of extrarenal 1,25 dihydroxy vitamin D produced by activated macrophages due to granulomatous inflammation. We present a case of very severe hypercalcemia due to GM.Case presentation: An 82-year-old lady presented to the emergency department due to deterioration in renal function an...

ea0104op3 | Oral Posters 1 – Endocrinology 1 | SFEIES24

Immunomodulation of severe graves’ disease: graves’-plasma cell depletion (PCD) trial

Grixti Lydia , Allinson Kathleen , Wolstenhulme Faye , Wason James , Gan Earn , Razvi Salman , Stewart Kathryn , Bennett Stuart , Al-Sharefi Ahmed , Artham Satish , Joshi Ashwin , Perros Petros , Quinton Richard , Napier Catherine , Mitchell Anna , Mamoojee Yaasir , Pearce Simon H.

Introduction: Hyperthyroid Graves’ Disease affects 3% of women and 0.5% of men over a lifetime, with only 50% of patients experiencing remission following antithyroid drug therapy. The humoral immune response involves the production of Thyroid Stimulating Hormone Receptor antibodies (TRAbs) from plasma cells. This study aims to provide proof of principle that Daratumumab, a monoclonal antibody targeting cell-surface CD-38 on plasma cells, could modulate the immune respons...

ea0086p92 | Neuroendocrinology and Pituitary | SFEBES2022

Natural history of non-functioning pituitary microadenomas – results from the UK NFA consortium

Hamblin Ross , Fountas Athanasios , Lithgow Kirstie , Loughrey Paul Benjamin , Bonanos Efstathios , Khalid Shinwari Shah , Mitchell Kirsten , Shah Syed , Grixti Lydia , Matheou Mike , Isand Kristina , McLaren David , Surya Ashutosh , Zubair Ullah Hafiz , Klaucane Katarina , Jayasuriya Anuradha , Bhatti Sumbal , Mavilakandy Akash , Ahsan Masato , Mathew Susan , Hussein Ziad , Jansz Thijs , Wunna Wunna , Ayuk John , Abraham Prakash , Drake William , Brooke Antonia , Baldeweg Stephanie E. , Sam Amir H. , Martin Niamh , Higham Claire , Reddy Narendra , Ahluwalia Rupa , Newell-Price John , Vamvakopoulos Joannis , Krishnan Amutha , Lansdown Andrew , Murray Robert D , Pal Aparna , Bradley Karin , Mamoojee Yaasir , Purewal Tejpal , Panicker Janki , Marie Freel E , Hasan Faisal , Kumar Mohit , Jose Biju , Hunter Steven , Karavitaki Niki

Background: The published data on the natural history of (presumed) non-functioning pituitary microadenomas (micro-NFAs) is possibly compromised by small sample sizes, short follow-up and inclusion of cases with other pathologies in the analyses.Objective: To clarify the long-term outcomes of micro-NFAs in a large cohort of patients.Methods: We conducted a multi-centre, retrospective, cohort study involving 22 UK endocrine departme...